Nabla Technologies Inc. raised $70 million in Series C funding to focus on agentic automation in healthcare.
HV Capital led the funding round with participation from Highland Europe, DST Global, Cathay Innovation, and Build Collective.
The total funding raised by Nabla now amounts to $120 million.
Nabla plans to expand into artificial intelligence agents to automate clinical workflows and reduce repetitive tasks.
The company's generative AI assistant for clinicians has been adopted by over 130 healthcare organizations globally, reducing time spent on documentation by over 50%.
Nabla aims to develop AI agents that can flag billing issues, access historical medical data, and provide tools for nurses and inpatient staff.
The company's revenue has increased over five times in the last six months, with more than 85,000 clinicians globally using its AI assistants.
Nabla's tools support over 20 million annual patient encounters, benefiting rural hospitals and children's medical facilities.
HV Capital partner Alexander Joel-Carbonell praised Nabla for its rapid scale, trustworthiness, and outstanding accuracy.
Nabla's co-founder Alex Lebrun aims to embed intelligent support into care delivery and enhance clinical workflows with customizable AI assistants.